摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-hydroxy-2-pentyl-nonanoic acid | 78057-93-9

中文名称
——
中文别名
——
英文名称
3-hydroxy-2-pentyl-nonanoic acid
英文别名
3-Hydroxy-2-pentyl-nonansaeure;2-n-Pentyl-3-hydroxynonanoic acid;3-hydroxy-2-pentylnonanoic acid
3-hydroxy-2-pentyl-nonanoic acid化学式
CAS
78057-93-9
化学式
C14H28O3
mdl
——
分子量
244.375
InChiKey
WGJRBERQBVBUQP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    17
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-hydroxy-2-pentyl-nonanoic acidpotassium hydrogensulfate乙酸酐 作用下, 生成 2-pentyl-non-2-enoic acid
    参考文献:
    名称:
    Lederer et al., Bulletin de la Societe Chimique de France, 1952, p. 413,416
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-oxo-2-pentyl-nonanoic acid methyl ester 在 作用下, 150.0 ℃ 、9.81 MPa 条件下, 生成 3-hydroxy-2-pentyl-nonanoic acid
    参考文献:
    名称:
    Lederer et al., Bulletin de la Societe Chimique de France, 1952, p. 413,416
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Peptides, their preparation and compositions containing them
    申请人:Rhone-Poulenc Industries
    公开号:US04916119A1
    公开(公告)日:1990-04-10
    Tripeptides of the general formula: ##STR1## wherein the symbols R, which may be the same or different represent hydrogen or a fatty acid residue (at least one of them representing a fatty acid residue), R.sub.1 represents hydroxy, amino or alkoxy and R.sub.2 and R.sub.3, which may be the same or different, represent hydrogen, carboxy, carbamoyl or alkoxycarbonyl radical (with the proviso that R.sub.2 and R.sub.3 cannot simultaneously represent a hydrogen atom), the alanine moiety being in the L form, the glutamic acid moiety being in the D form, the lysine moiety (when R.sub.2 or R.sub.3 =a hydrogen atom) being in the L form and the 2,6-diaminopimelic acid moiety or its derivatives (when R.sub.2 and/or R.sub.3 =carboxy, carbamoyl or alkoxycarbonyl) being in the D,D, L,L, D,D/L,L (racemic) or D,L (meso) form, and salts thereof, possess immunological adjuvant and immunostimulant activity.
    通式为:##STR1## 的三肽,其中符号R,可以相同或不同,代表氢或脂肪酸残基(其中至少一个代表脂肪酸残基),R.sub.1代表羟基,氨基或烷氧基,R.sub.2和R.sub.3,可以相同或不同,代表氢,羧基,氨基甲酰基或烷氧羰基基团(但须满足R.sub.2和R.sub.3不能同时代表氢原子),丙氨酸部分为L型,谷氨酸部分为D型,赖氨酸部分(当R.sub.2或R.sub.3=氢原子时)为L型,2,6-二氨基庚二酸部分或其衍生物(当R.sub.2和/或R.sub.3=羧基,氨基甲酰基或烷氧羰基时)为D,D,L,L,D,D/L,L(外消旋)或D,L(内消旋)型,并且它们的盐具有免疫佐剂和免疫刺激活性。
  • Dipeptides, their preparation and compositions containing them
    申请人:Rhone-Poulenc Industries
    公开号:US04362716A1
    公开(公告)日:1982-12-07
    Dipeptides of the formula: ##STR1## in which R-CO represents a fatty acid residue and the symbols R.sub.1, which are identical or different, represent hydroxyl, amino or alkoxy containing 1 to 4 carbon atoms, which is optionally substituted by phenyl or nitrophenyl, it being understood that the alanine is in the L form and the glutamic acid or derivative thereof is in the D form, and their salts are immunological adjuvants and immunostimulants. They may be made using methods known per se in peptide chemistry and may be incorporated in pharmaceutical compositions.
    公式为:##STR1##的二肽,其中R-CO代表脂肪酸残基,符号R.sub.1代表含有1至4个碳原子的羟基,氨基或烷氧基,可以选择地被苯基或硝基苯基取代,其中丙氨酸为L型,谷氨酸或其衍生物为D型,其盐是免疫佐剂和免疫刺激剂。它们可以使用已知的肽化学方法制备,并可以纳入制药组合物中。
  • US4362716A
    申请人:——
    公开号:US4362716A
    公开(公告)日:1982-12-07
  • US4916119A
    申请人:——
    公开号:US4916119A
    公开(公告)日:1990-04-10
  • Lederer et al., Bulletin de la Societe Chimique de France, 1952, p. 413,416
    作者:Lederer et al.
    DOI:——
    日期:——
查看更多